Initial Management of Acute Decompensated Heart Failure
The initial management of acute decompensated heart failure should include oxygen therapy, non-invasive ventilation for respiratory distress, intravenous loop diuretics for fluid overload, and identification of precipitating factors, with appropriate hemodynamic monitoring throughout treatment. 1, 2
Immediate Assessment and Interventions
- Assess oxygen saturation and administer oxygen therapy to patients with SpO2 <90% to relieve hypoxemia 1, 2
- Initiate non-invasive ventilation (NIV) promptly in patients with acute pulmonary edema showing respiratory distress 1, 2
- Continuous positive airway pressure (CPAP) is feasible in pre-hospital settings
- Pressure-support positive end-expiratory pressure (PS-PEEP) is preferred for patients with acidosis and hypercapnia, particularly those with COPD history 1
- Obtain ECG to identify potential acute coronary syndrome and assess for arrhythmias 1, 2
- Measure B-type natriuretic peptide (BNP) or NT-proBNP levels to confirm diagnosis in patients with dyspnea 1, 2
- Identify potential precipitating factors including 1, 2:
- Acute coronary syndromes
- Severe hypertension
- Atrial and ventricular arrhythmias
- Infections
- Pulmonary emboli
- Renal failure
- Medication or dietary non-compliance
Diuretic Therapy
- For patients with evidence of fluid overload, administer intravenous loop diuretics without delay 1
- Dosing recommendations 1, 2:
- New-onset HF or no maintenance diuretic therapy: Furosemide 40 mg IV
- Established HF or on chronic oral diuretic therapy: IV bolus at least equivalent to oral daily dose
- When diuresis is inadequate to relieve congestion, intensify the diuretic regimen by 1:
- Increasing doses of loop diuretics
- Adding a second diuretic (metolazone, spironolactone, or IV chlorothiazide)
- Using continuous infusion of a loop diuretic
Vasodilator Therapy
- Consider intravenous vasodilators for patients with normal to high blood pressure (SBP >110 mmHg) 1, 3
- Avoid vasodilators in patients with SBP <110 mmHg 1, 3
Inotropic Support
- Reserve intravenous inotropic drugs (dobutamine, milrinone) for patients with hypotension (SBP <90 mmHg) associated with hypoperfusion and elevated cardiac filling pressures 1, 4, 5
- Milrinone is indicated for short-term IV treatment of patients with acute decompensated heart failure and may be more effective than dobutamine in patients receiving beta-blockers 4, 6
- Dobutamine is indicated for inotropic support in short-term treatment of cardiac decompensation due to depressed contractility 5
- Avoid routine use of inotropes in patients without signs of hypoperfusion due to safety concerns 3
Hemodynamic Monitoring
- Monitor fluid intake and output, vital signs, body weight (measured at the same time daily), and clinical signs of systemic perfusion and congestion 1, 2
- Measure daily serum electrolytes, urea nitrogen, and creatinine during IV diuretic use or active titration of HF medications 1
- Consider invasive hemodynamic monitoring in patients with respiratory distress or impaired perfusion when adequacy of intracardiac filling pressures cannot be determined from clinical assessment 1
Special Considerations
- For cardiogenic shock (SBP <90 mmHg with signs of hypoperfusion despite adequate filling status), transfer to a tertiary care center with 24/7 cardiac catheterization and mechanical circulatory support capabilities 2, 3
- Avoid routine use of opioids as they may be associated with higher rates of mechanical ventilation, ICU admission, and mortality 1, 3
- For patients with chronic heart failure on evidence-based therapies (ACEIs/ARBs, beta-blockers):
Criteria for ICU/CCU Admission
- Patients with significant dyspnea or hemodynamic instability should be admitted to a high-dependency setting 2, 3
- Consider ICU admission for patients with 2, 3:
- Respiratory rate >25 breaths/min
- SaO2 <90% despite oxygen therapy
- Use of accessory muscles for breathing
- Systolic BP <90 mmHg
- Need for intubation
- Signs of hypoperfusion
By following this systematic approach to the initial management of acute decompensated heart failure, clinicians can effectively stabilize patients and improve outcomes while identifying and addressing underlying precipitating factors 7, 8, 9, 10.